2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Cancer Immunology Research CANCER IMMUNOL RES (此期刊被最新的JCR期刊SCIE收录) LetPub评分 8.9
51人评分
我要评分
声誉 10.0 影响力 7.9 速度 9.7 | |||||||||||||||||||||||||||||||
期刊ISSN | 2326-6066 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||
E-ISSN | 2326-6074 | |||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 8.1 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:6.059 | |||||||||||||||||||||||||||||||
2023-2024自引率 | 2.50%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 10.1 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 1.93 | |||||||||||||||||||||||||||||||
h-index | 62 | |||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | http://cancerimmunolres.aacrjournals.org/ | |||||||||||||||||||||||||||||||
期刊投稿网址 | https://cir.msubmit.net/cgi-bin/main.plex | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Immunology Research的语言要求,还能让Cancer Immunology Research编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Immunology Research编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||||||||
通讯方式 | 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404 | |||||||||||||||||||||||||||||||
出版商 | American Association for Cancer Research Inc. | |||||||||||||||||||||||||||||||
涉及的研究方向 | ONCOLOGY-IMMUNOLOGY | |||||||||||||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | ||||||||||||||||||||||||||||||||
出版年份 | 0 | |||||||||||||||||||||||||||||||
年文章数 | 114点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 29.13% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 95.61% | |||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2326-6066%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Cancer Immunology Research顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | HRS Regulates Small Extracellular Vesicle PD-L1 Secretion and Is Associated with Anti-PD-1 Treatment Efficacy Author: Xiao, Bo -Lin; Wang, Xiao-Le; Xia, Hou-Fu; Wang, Kui-Ming; Chen, Zhuo-Kun; Zhong, Ya-Hua; Jiang, Huan-Gang; Zhou, Fu-Xiang; Wang, Wei; Chen, Gai-Li; Chen, Gang Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 2, pp. 228-240. DOI: 10.1158/2326-6066.CIR-22-0277 PubMed DOI |
2. | Extracellular Vesicle-Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis Author: Wang, Fang; Niu, Yuequn; Chen, Kelie; Yuan, Xiaoyu; Qin, Yuheng; Zheng, Fang; Cui, Zhenyan; Lu, Weiguo; Wu, Yihua; Xia, Dajing Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 2, pp. 199-216. DOI: 10.1158/2326-6066.CIR-22-0410 PubMed DOI |
3. | HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Chemotaxis and Recruiting of Immune Cells Author: Li, Lili; Hao, Shumin; Gao, Meiling; Liu, Junxiao; Xu, Xin; Huang, Jianfei; Cheng, Genhong; Yang, Heng Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 5, pp. 657-673. DOI: 10.1158/2326-6066.CIR-22-0317 PubMed DOI |
4. | Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1-Independent Manner Author: Long, Yiru; Chen, Runqiu; Yu, Xiaolu; Tong, Yongliang; Peng, Xionghua; Li, Fanglin; Hu, Chao; Sun, Jianhua; Gong, Likun Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 2, pp. 241-260. DOI: 10.1158/2326-6066.CIR-22-0439 PubMed DOI |
5. | Discovery of Podofilox as a Potent cGAMP-STING Signaling Enhancer with Antitumor Activity Author: Han, Jing; Hu, Shuiqing; Hu, Yawei; Xu, Yifang; Hou, Yanfei; Yang, Yinlong; Su, Huili; Zhang, Zhengyin; Liu, Peng; Sun, Xuxu; Zhang, Conggang Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 5, pp. 583-599. DOI: 10.1158/2326-6066.CIR-22-0483 PubMed DOI |
6. | CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer Author: Wei, Ye; Xu, Tingting; Li, Chong; Zhou, Xin; Qian, Wei; Shen, Chunying; Wang, Qifeng; Xing, Xing; Ou, Xiaomin; He, Xiayun; Yin, Hongmei; Hu, Chaosu; Wang, Yu; Ji, Qinghai; Su, Fengtao; Lu, Xueguan Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 3, pp. 306-319. DOI: 10.1158/2326-6066.CIR-22-0454 PubMed DOI |
7. | Cancer Cell Resistance to IFNg Can Occur via Enhanced Double-Strand Break Repair Pathway Activity Author: Han, Tong; Wang, Xujun; Shi, Sailing; Zhang, Wubing; Wang, Jue; Wu, Qiu; Li, Ziyi; Fu, Jingxin; Zheng, Rongbin; Zhang, Jiamin; Tang, Qin; Zhang, Peng; Wang, Chenfei Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 3, pp. 381-398. DOI: 10.1158/2326-6066.CIR-22-0056 PubMed DOI |
8. | Autoantibodies Drive Heart Damage Caused by Concomitant Radiation and PD-1 Blockade Author: Yan, Bo; Hooper, D. Craig; Yuan, Zhiyong; Wang, Changli; Chen, Yulong; Lu, Bo Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 4, pp. 546-555. DOI: 10.1158/2326-6066.CIR-21-0839 PubMed DOI |
9. | Tumor Cell-Derived Microparticles Induced by Methotrexate Augment T-cell Antitumor Responses by Downregulating Expression of PD-1 in Neutrophils Author: Xu, Pingwei; Zhang, Xiaojie; Chen, Kai; Zhu, Meng; Jia, Ru; Zhou, Qingwei; Yang, Jintao; Dai, Juqin; Jin, Yuepeng; Shi, Keqing Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 4, pp. 501-514. DOI: 10.1158/2326-6066.CIR-22-0595 PubMed DOI |
10. | Herpes Virus Entry Mediator Costimulation Signaling Enhances CAR T-cell Efficacy Against Solid Tumors Through Metabolic Reprogramming Author: Sun, Shishuo; Huang, Chao; Lu, Mengmeng; Xu, Heng; Yuan, Yifan; Zhao, Wanxin; Hu, Xiaolei; Wang, Bixi; Zhang, Wei; Gao, Xiaoge; Zheng, Junnian; Su, Lishan; Zhang, Qing Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 4, pp. 515-529. DOI: 10.1158/2326-6066.CIR-22-0531 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室